Trial · NCT00565851
Adverse events3,664
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 3,664
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Allergy/Immunology - Other | Immune system disorders | Arm I (no Surgery; Carboplatin and Paclitaxel) | 0 | 316 | |
| other | Allergy/Immunology - Other | Immune system disorders | Arm II (no Surgery; Carboplatin, Paclitaxel and Bevacizumab) | 2 | 456 | |
| other | Allergy/Immunology - Other | Immune system disorders | Arm III (Surgery; Carboplatin and Paclitaxel) | 0 | 33 | |
| other | Allergy/Immunology - Other | Immune system disorders | Arm IV (Surgery; Carboplatin, Paclitaxel and Bevacizumab) | 1 | 165 | |
| other | Allergy/Immunology - Other | Immune system disorders | Arm V (no Surgery; Carboplatin and Gemcitabine) | 0 | 6 | |
| other | Allergy/Immunology - Other | Immune system disorders | Arm VI (no Surgery; Carboplatin, Gemcitabine and Bevacizumab) | 0 | 34 | |
| other | Allergy/Immunology - Other | Immune system disorders | Arm VII (Surgery; Carboplatin and Gemcitabine) | 0 | 5 | |
| other | Allergy/Immunology - Other | Immune system disorders | Arm VIII (Surgery; Carboplatin, Gemcitabine and Bevacizumab) | 0 | 37 | |
| other | Allergic Reaction/Hypersensitivity | Immune system disorders | Arm I (no Surgery; Carboplatin and Paclitaxel) | 76 | 316 | |
| other | Allergic Reaction/Hypersensitivity | Immune system disorders | Arm II (no Surgery; Carboplatin, Paclitaxel and Bevacizumab) | 86 | 456 | |
| other | Allergic Reaction/Hypersensitivity | Immune system disorders | Arm III (Surgery; Carboplatin and Paclitaxel) | 6 | 33 | |
| other | Allergic Reaction/Hypersensitivity | Immune system disorders | Arm IV (Surgery; Carboplatin, Paclitaxel and Bevacizumab) | 16 | 165 | |
| other | Allergic Reaction/Hypersensitivity | Immune system disorders | Arm V (no Surgery; Carboplatin and Gemcitabine) | 1 | 6 | |
| other | Allergic Reaction/Hypersensitivity | Immune system disorders | Arm VI (no Surgery; Carboplatin, Gemcitabine and Bevacizumab) | 0 | 34 | |
| other | Allergic Reaction/Hypersensitivity | Immune system disorders | Arm VII (Surgery; Carboplatin and Gemcitabine) | 1 | 5 | |
| other | Allergic Reaction/Hypersensitivity | Immune system disorders | Arm VIII (Surgery; Carboplatin, Gemcitabine and Bevacizumab) | 3 | 37 | |
| other | Vasculitis | Immune system disorders | Arm I (no Surgery; Carboplatin and Paclitaxel) | 0 | 316 | |
| other | Vasculitis | Immune system disorders | Arm II (no Surgery; Carboplatin, Paclitaxel and Bevacizumab) | 1 | 456 | |
| other | Vasculitis | Immune system disorders | Arm III (Surgery; Carboplatin and Paclitaxel) | 0 | 33 | |
| other | Vasculitis | Immune system disorders | Arm IV (Surgery; Carboplatin, Paclitaxel and Bevacizumab) | 0 | 165 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00565851/events